Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20
- 1 October 1989
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 164 (1), 468-473
- https://doi.org/10.1016/0006-291x(89)91743-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- 20 KDa homologous restriction factor of complement resembles T cell activating proteinBiochemical and Biophysical Research Communications, 1989
- Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.JCI Insight, 1989
- A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complementInternational Immunology, 1989
- Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1987
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Restriction of alternative complement pathway activation by sialosylglycolipidsNature, 1982
- Mechanisms of Immune Lysis of Red Blood Cells In Vitro I. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CELLSJCI Insight, 1973
- Inhibition of complement by a substance isolated from human erythrocytes—II: Studies on the site and mechanism of actionImmunochemistry, 1969
- Inhibition of complement by a substance isolated from human erythrocytes — I: Extraction from human erythrocyte stromataImmunochemistry, 1969
- The influence ofpH on in-vitro hæmolysis in nocturnal hæmoglobinuriaThe Journal of Pathology and Bacteriology, 1943